Agents used in photodynamic therapy

Reviews in Contemporary Pharmacotherapy

Volumn 10, Issue 1, 1999, Pages 19-24

  Kessel, David ^a   Dougherty, Thomas J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN I; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PURPURIN; TEXAPHYRIN; UNCLASSIFIED DRUG;

DRUG SAFETY; HUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; REVIEW;

EID: 0032936336     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Allen R, Kessel D, Tharratt RS, Volz W. Photodynamic therapy of superficial malignancies with NPe6 in man. In: Spinelli P, DalFante M, Marchese R, eds. Photodynamic therapy and biomedical lasers. New York: Elsevier Science, 1992: 441-445.
2. Allison BA, Crespo MT, Jain AK, Richter AM, Hsiang YN, Levy JG. Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Photochem Photobiol 1997; 65: 877-883.
3. Barr H, Tralau CJ, MacRobert AJ et al. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br J Cancer 1987; 56: 111-118.
4. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Frasner N. Eradication of high-grade dysplasia in columnar-lined (Barren's) oesophagus by photodynamic therapy with endogenously generated protoporphyrins IX. Lancet 1996; 348: 584-585.
5. Berenbaum MC, Bonnett R, Scourides PA. In vivo biological activity of the components of haematoporphyrin derivative, Br J Cancer 1982; 45: 571-581.
6. Biel MA. Photodynamic therapy and the treating of head and neck cancers. J Clin Laser Radiat Surg 1996; 14: 239-244.
7. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995; 24: 19-33.
8. Bonnett R, White RD, Winfield U-J, Berenbaum MC. Hydroporphyrins of the meso-tetrahydroxyphenyl porphyrin series as tumour photosensitizers. Biochem J 1989; 261: 277-280.
9. Bown SG, Millson CE. Photodynamic therapy in gastroenterology. Gut 1997; 41: 5-7.
10. Bown SG, Tralau CJ, Coleridge-Smith PD et al. Photodynamic therapy with porphyrin and phthalocyanine sensitisation in normal rat liver. Br J Cancer 1986; 54: 43-52.
11. Dilkes MG, De Jode ML, Rowntree-Taylor A. m-THPC photodynamic therapy for head and neck cancer. Lasers Med Sci 1997; 11: 23-30.
12. Doiron DR, Svaasand LO, Profio AE. Light dosimetry in tissue: application to photoradiation therapy. In: Kessel D, Dougherty TJ, eds. Advances in experimental medicine and biology. New York: Plenum Press, 1983; 160: 63-77.
13. Dougherty TJ. Studies on the structure of porphyrins contained in Photofrin II. Photochem Photobiol 1987; 46: 569-573.
14. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumours. Cancer Res 1978; 38: 2628-2635.
15. Dougherty TJ, Henderson BW, Schwartz S, Winkelman JW, Lipson RL. Historical perspective. In: Henderson BW, Dougherty TJ, eds. Photodynamic therapy. New York: Marcel Dekker, 1992: 1-15.
16. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102: 1319-1322.
17. Furuse K, Fukuoka M, Kato H. Prospective phase II study on photodynamic therapy with photofrin II for controlling localized early-stage lung cancer. J Clin Oncol 1993; 11: 1852-1857.
18. Glanzmann T, Hadjur C, Zellweher M et al. Pharmacokinetics of Tetra (m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Photochem Photobiol 1998; 67: 596-602.
19. 14C]-hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979; 39: 146-151.